{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:34Z","timestamp":1792782814754,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nagoya University","id":[{"id":"https:\/\/ror.org\/04chrp450","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"DOI":"10.1007\/s00540-026-03903-9","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:18:31Z","timestamp":1789967911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of combination therapy with recombinant thrombomodulin and antithrombin on outcomes in patients with sepsis-induced disseminated intravascular coagulation in a surgical intensive care unit: a retrospective observational study"],"prefix":"10.1007","author":[{"given":"Masashi","family":"Takakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-1230","authenticated-orcid":false,"given":"Tasuku","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"3903_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1056\/NEJMoa022139","volume":"348","author":"GS Martin","year":"1979","unstructured":"Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 1979;348:1546\u201354.","journal-title":"N Engl J Med"},{"key":"3903_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"1990","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 1990;395:200\u201311.","journal-title":"Lancet"},{"key":"3903_CR3","first-page":"313","volume":"3","author":"K Yamakawa","year":"2020","unstructured":"Yamakawa K, Ohbe H, Taniguchi K, Matsui H, Fushimi K, Yasunaga H. Time trends of the outcomes and treatment options for disseminated intravascular coagulation: a nationwide observational study in Japan. JMA. 2020;3:313\u201320.","journal-title":"JMA"},{"key":"3903_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","volume":"178","author":"S Gando","year":"2019","unstructured":"Gando S, Shiraishi A, Yamakawa K, Ogura H, Saitoh D, Fujishima S, et al. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res. 2019;178:182\u20138.","journal-title":"Thromb Res"},{"key":"3903_CR5","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","volume":"132","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology. 2020;132:1238\u201345.","journal-title":"Anesthesiology"},{"key":"3903_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0039-1694995","volume":"46","author":"T Iba","year":"2020","unstructured":"Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost. 2020;46:89\u201395.","journal-title":"Semin Thromb Hemost"},{"key":"3903_CR7","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1177\/1076029618806424","volume":"24","author":"C Papageorgiou","year":"2018","unstructured":"Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J, et al. Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018;24:8S-28S.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Suppl","key":"3903_CR8","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.1097\/00003246-200205001-00023","volume":"30","author":"JF Dhainaut","year":"2002","unstructured":"Dhainaut JF, Yan SB, Cariou A, Mira JP. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Crit Care Med. 2002;30(Suppl):S318\u201324.","journal-title":"Crit Care Med"},{"key":"3903_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.thromres.2023.05.009","volume":"226","author":"H Kato","year":"2023","unstructured":"Kato H, Hagihara M, Asai N, Umemura T, Hirai J, Mori N, et al. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation \u2013 a meta-analysis. Thromb Res. 2023;226:165\u201372.","journal-title":"Thromb Res"},{"key":"3903_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jth.14812","volume":"18","author":"E Valeriani","year":"2020","unstructured":"Valeriani E, Squizzato A, Gallo A, Porreca E, Vincent JL, Iba T, et al. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis. J Thromb Haemost. 2020;18:1618\u201325.","journal-title":"J Thromb Haemost"},{"key":"3903_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0038-1676345","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019;119:56\u201365.","journal-title":"Thromb Haemost"},{"key":"3903_CR12","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","volume":"41","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41:2069\u201379.","journal-title":"Crit Care Med"},{"key":"3903_CR13","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial. JAMA. 2019;321:1993\u20132002.","journal-title":"JAMA"},{"key":"3903_CR14","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1016\/S0021-9258(19)43472-8","volume":"248","author":"RD Rosenberg","year":"1973","unstructured":"Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem. 1973;248:6490\u2013505.","journal-title":"J Biol Chem"},{"key":"3903_CR15","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","volume":"1","author":"JA Huntington","year":"2003","unstructured":"Huntington JA. Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost. 2003;1:1535\u201349.","journal-title":"J Thromb Haemost"},{"key":"3903_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1160\/TH15-08-0687","volume":"115","author":"JH Levy","year":"2016","unstructured":"Levy JH, Sniecinski RM, Welsby IJ, Levi M. Antithrombin: anti-inflammatory properties and clinical applications. Thromb Haemost. 2016;115:712\u201328.","journal-title":"Thromb Haemost"},{"key":"3903_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/cc4822","volume":"10","author":"CJ Wiedermann","year":"2006","unstructured":"Wiedermann CJ. Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis. Crit Care. 2006;10:209.","journal-title":"Crit Care"},{"key":"3903_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1177\/1076029618770273","volume":"24","author":"T Iba","year":"2018","unstructured":"Iba T, Arakawa M, Levy JH, Yamakawa K, Koami H, Hifumi T, et al. Sepsis-induced coagulopathy and Japanese association for acute medicine DIC in coagulopathic patients with decreased antithrombin and treated by antithrombin. Clin Appl Thromb Hemost. 2018;24:1020\u20136.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3903_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.thromres.2019.07.002","volume":"181","author":"T Matsubara","year":"2019","unstructured":"Matsubara T, Yamakawa K, Umemura Y, Gando S, Ogura H, Shiraishi A, et al. Significance of plasma fibrinogen level and antithrombin activity in sepsis: a multicenter cohort study using a cubic spline model. Thromb Res. 2019;181:17\u201323.","journal-title":"Thromb Res"},{"key":"3903_CR20","volume":"2","author":"M Allingstrup","year":"2016","unstructured":"Allingstrup M, Wetterslev J, Ravn FB, M\u00f8ller AM, Afshari A. Antithrombin III for critically ill patients. Cochrane Database Syst Rev. 2016;2:CD005370.","journal-title":"Cochrane Database Syst Rev"},{"key":"3903_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/01.mbc.0000245302.18010.40","volume":"17","author":"CJ Wiedermann","year":"2006","unstructured":"Wiedermann CJ, Kaneider NC. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis. Blood Coagul Fibrinolysis. 2006;17:521\u20136.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3903_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40560-025-00776-0","volume":"13","author":"N Shime","year":"2025","unstructured":"Shime N, Nakada TA, Yatabe T, Yamakawa K, Aoki Y, Inoue S, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2024. J Intensive Care. 2025;13:15.","journal-title":"J Intensive Care"},{"key":"3903_CR23","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"3903_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.thromres.2014.04.015","volume":"134","author":"T Iba","year":"2014","unstructured":"Iba T, Miki T, Hashiguchi N, Tabe Y, Nagaoka I. Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemicrats. Thromb Res. 2014;134:169\u201373.","journal-title":"Thromb Res"},{"key":"3903_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/cc8210","volume":"13","author":"T Iba","year":"2009","unstructured":"Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T, Ohno Y. Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Crit Care. 2009;13:R203.","journal-title":"Crit Care"},{"key":"3903_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13613-017-0332-z","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Hagiwara A, Saitoh D, Anan H, Ueki Y, Sato K, et al. Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation. Ann Intensive Care. 2017;7:110.","journal-title":"Ann Intensive Care"},{"key":"3903_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40560-019-0419-8","volume":"8","author":"J Suzuki","year":"2020","unstructured":"Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, et al. The effect of antithrombin added to recombinant human-soluble thrombomodulin for severe community-acquired pneumonia-associated disseminated intravascular coagulation: a retrospective cohort study using a nationwide inpatient database. J Intensive Care. 2020;8:8.","journal-title":"J Intensive Care"},{"key":"3903_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1076029618755948","volume":"24","author":"Y Umemura","year":"2018","unstructured":"Umemura Y, Yamakawa K, Hayakawa M, Kudo D, Fujimi S. Concomitant versus individual administration of antithrombin and thrombomodulin for sepsis-induced disseminated intravascular coagulation: a nationwide Japanese registry study. Clin Appl Thromb Hemost. 2018;24:734\u201340.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3903_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12959-023-00579-z","volume":"22","author":"T Totoki","year":"2024","unstructured":"Totoki T, Makino Y, Yamakawa K, Koami H, Wada T, Ito T, et al. Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis. Thromb J. 2024;22:10.","journal-title":"Thromb J"},{"key":"3903_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"3903_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/107602960501100108","volume":"11","author":"S Gando","year":"2005","unstructured":"Gando S, Wada H, Asakura H, Iba T, Eguchi Y, Okamoto K, et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost. 2005;11:71\u20136.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3903_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"key":"3903_CR33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Anger\u00e5s U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8:202\u20134.","journal-title":"J Thromb Haemost"},{"key":"3903_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1037\/a0019623","volume":"15","author":"VS Harder","year":"2010","unstructured":"Harder VS, Stuart EA, Anthony JC. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods. 2010;15:234\u201349.","journal-title":"Psychol Methods"},{"key":"3903_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/chi.2015.0249","volume":"12","author":"DL Coffman","year":"2016","unstructured":"Coffman DL, Balantekin KN, Savage JS. Using propensity score methods to assess causal effects of mothers\u2019 dieting behavior on daughters\u2019 early dieting behavior. Child Obes. 2016;12:334\u201340.","journal-title":"Child Obes"},{"key":"3903_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.950","volume":"11","author":"T Tsuchida","year":"2024","unstructured":"Tsuchida T, Makino Y, Wada T, Ushio N, Totoki T, Fujie N, et al. Efficacy of antithrombin administration for patients with sepsis: a systematic review, meta-analysis, and meta-regression. Acute Med Surg. 2024;11:e950.","journal-title":"Acute Med Surg"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-026-03903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00540-026-03903-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-026-03903-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:01:55Z","timestamp":1789970515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00540-026-03903-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":36,"alternative-id":["3903"],"URL":"https:\/\/doi.org\/10.1007\/s00540-026-03903-9","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}